affymax inc (AFFY:NASDAQ GS)

Executive Profile*

Background*

Dr. Robert (Bob) F. Venteicher, PhD served as Senior Vice President of Technical Operations at Affymax, Inc., from June 2008 to March 31, 2013 and served as its Chief Technology Officer until March 31, 2013. Dr. Venteicher served as a Vice President of Technical Operations at Affymax, Inc., from August 14, 2007 to June 2008. Dr. Venteicher oversaw manufacturing and process development, quality and facility operations for Affymax. He has nearly 30 years of experience ... in pharmaceutical and biotechnology drug development. Dr. Venteicher is experienced in managing supply chain and quality strategies for contracted and collaborative business alliances for development and commercial products sourced globally. His drug development experience includes work on vaccines, antibodies, recombinant proteins, toxins, small molecule organics and peptides in the therapeutic areas of oncology and cardiovascular, neurologic, infectious and inflammatory diseases. Dr. Venteicher joined Affymax from Elan Pharmaceuticals, Inc., where he served as its Vice President of R&D Quality and Compliance and held several positions from 1995 to 2007. Prior to Elan Pharmaceuticals, he served as Vice President of Quality Assurance and Quality Control of Univax Biologics, Inc. and held several positions from 1992 to 1995. He served as Head of R&D Pharmaceutical Quality Control and Associate Director of Bioprocess and Analytical Development of Centocor Inc. from 1988 to 1992. He also held scientific and management positions with increasing responsibilities during his 10-year tenure at Hoffmann LaRoche, Inc. Dr. Venteicher holds a BS in Chemistry from Iowa State University and his PhD in Chemistry from Pennsylvania State University. He completed postdoctoral training in Biochemistry and Biophysics at Johnson Research Foundation, University of Pennsylvania.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
AFFY:US	$1.39 USD	-0.01

COMPETITOR COMPENSATION